Literature DB >> 17934720

Adenylyl cyclase type 6 overexpression selectively enhances beta-adrenergic and prostacyclin receptor-mediated inhibition of cardiac fibroblast function because of colocalization in lipid rafts.

Xiaoqiu Liu1, Muthusamy Thangavel, Shu Qiang Sun, Joseph Kaminsky, Penden Mahautmr, Jeremiah Stitham, John Hwa, Rennolds S Ostrom.   

Abstract

Cardiac fibroblasts produce and degrade extracellular matrix and are critical in regulating cardiac remodeling and hypertrophy. Fibroblasts are activated by factors such as transforming growth factor beta and inhibited by agents that elevate 3',5'-cyclic adenosine monophosphate (cAMP) levels. cAMP signal generation and response is known to be compartmentalized in many cell types in part through the colocalization of receptors and specific adenylyl cyclase isoforms in lipid rafts and caveolae. The present study sought to define the localization of key G protein-coupled receptors with adenylyl cyclase type 6 (AC6) in lipid rafts of rat cardiac fibroblasts and to determine if this colocalization was functionally relevant. We found that cardiac fibroblasts produce cAMP in response to agonists for beta-adrenergic (isoproterenol), prostaglandin EP2 (butaprost), adenosine (adenosine-5'-N-ethylcarboxamide, NECA), and prostacyclin (beraprost) receptors. Overexpression of AC6 increased cAMP production stimulated by isoproterenol and beraprost but not by butaprost or NECA. A key function of fibroblasts is the production of collagen. Isoproterenol- and beraprostmediated inhibition of collagen synthesis was also enhanced by AC6 overexpression, while inhibition by butaprost and NECA were unaltered. Lipid raft fractions from cardiac fibroblasts contain the preponderance of beta-adrenergic receptors and AC6 but exclude EP2 receptors. While we could not determine the localization of native prostacyclin receptors, we were able to determine that epitope-tagged prostanoid IP receptors (IPR) expressed in COS7 cells did localize, in part, in lipid raft fractions. These findings indicate that IP receptors are expressed in lipid rafts and can activate raft-localized AC isoforms. AC6 is completely compartmentized in lipid raft domains where it is activated solely by coresident G protein-coupled receptors to regulate cardiac fibroblast function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17934720      PMCID: PMC2665709          DOI: 10.1007/s00210-007-0196-0

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  38 in total

1.  Residence of adenylyl cyclase type 8 in caveolae is necessary but not sufficient for regulation by capacitative Ca(2+) entry.

Authors:  Karen E Smith; Chen Gu; Kent A Fagan; Biao Hu; Dermot M F Cooper
Journal:  J Biol Chem       Date:  2001-12-13       Impact factor: 5.157

Review 2.  Caveolae: from cell biology to animal physiology.

Authors:  Babak Razani; Scott E Woodman; Michael P Lisanti
Journal:  Pharmacol Rev       Date:  2002-09       Impact factor: 25.468

Review 3.  Regulation and organization of adenylyl cyclases and cAMP.

Authors:  Dermot M F Cooper
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

Review 4.  Regulation of endothelial nitric oxide synthase: location, location, location.

Authors:  Philip W Shaul
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

5.  Angiotensin II enhances adenylyl cyclase signaling via Ca2+/calmodulin. Gq-Gs cross-talk regulates collagen production in cardiac fibroblasts.

Authors:  Rennolds S Ostrom; Jennifer E Naugle; Miki Hase; Caroline Gregorian; James S Swaney; Paul A Insel; Laurence L Brunton; J Gary Meszaros
Journal:  J Biol Chem       Date:  2003-04-23       Impact factor: 5.157

6.  cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts.

Authors:  Xiaoqiu Liu; Rennolds S Ostrom; Paul A Insel
Journal:  Am J Physiol Cell Physiol       Date:  2004-01-07       Impact factor: 4.249

7.  Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors.

Authors:  Leonard J Foster; Carmen L De Hoog; Matthias Mann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-30       Impact factor: 11.205

8.  Long-term-desensitization of prostacyclin receptors is independent of the C-terminal tail.

Authors:  Andreas Hasse; Sigrid M Nilius; Karsten Schrör; Jutta Meyer-Kirchrath
Journal:  Biochem Pharmacol       Date:  2003-06-15       Impact factor: 5.858

Review 9.  Lipid rafts: bringing order to chaos.

Authors:  Linda J Pike
Journal:  J Lipid Res       Date:  2003-02-01       Impact factor: 5.922

10.  Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: expression in caveolin-rich and noncaveolin domains.

Authors:  Rennolds S Ostrom; Xiaoqiu Liu; Brian P Head; Caroline Gregorian; Tammy M Seasholtz; Paul A Insel
Journal:  Mol Pharmacol       Date:  2002-11       Impact factor: 4.436

View more
  15 in total

1.  Fibroblast-specific expression of AC6 enhances beta-adrenergic and prostacyclin signaling and blunts bleomycin-induced pulmonary fibrosis.

Authors:  Xiaoqiu Liu; Fengying Li; Shu Qiang Sun; Muthusamy Thangavel; Joseph Kaminsky; Louisa Balazs; Rennolds S Ostrom
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-03-26       Impact factor: 5.464

Review 2.  cAMP Signaling Compartmentation: Adenylyl Cyclases as Anchors of Dynamic Signaling Complexes.

Authors:  Timothy B Johnstone; Shailesh R Agarwal; Robert D Harvey; Rennolds S Ostrom
Journal:  Mol Pharmacol       Date:  2017-12-07       Impact factor: 4.436

3.  Adenylyl cyclase 2 selectively couples to E prostanoid type 2 receptors, whereas adenylyl cyclase 3 is not receptor-regulated in airway smooth muscle.

Authors:  Amy S Bogard; Piyatilake Adris; Rennolds S Ostrom
Journal:  J Pharmacol Exp Ther       Date:  2012-05-22       Impact factor: 4.030

4.  Heterodimerization with the prostacyclin receptor triggers thromboxane receptor relocation to lipid rafts.

Authors:  Salam Ibrahim; Ann McCartney; Nune Markosyan; Emer M Smyth
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-15       Impact factor: 8.311

5.  Study of adenylyl cyclase-GαS interactions and identification of novel AC ligands.

Authors:  Appalaraju Jaggupilli; Premnath Dhanaraj; Alexander Pritchard; John L Sorensen; Shyamala Dakshinamurti; Prashen Chelikani
Journal:  Mol Cell Biochem       Date:  2018-01-11       Impact factor: 3.396

6.  Human bronchial smooth muscle cells express adenylyl cyclase isoforms 2, 4, and 6 in distinct membrane microdomains.

Authors:  Amy S Bogard; Congfeng Xu; Rennolds S Ostrom
Journal:  J Pharmacol Exp Ther       Date:  2011-01-12       Impact factor: 4.030

Review 7.  cAMP and Epac in the regulation of tissue fibrosis.

Authors:  Paul A Insel; Fiona Murray; Utako Yokoyama; Silvia Romano; Hongruo Yun; Loren Brown; Aaron Snead; David Lu; Nakon Aroonsakool
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 8.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 9.  Adenylyl cyclase--A-kinase anchoring protein complexes: the next dimension in cAMP signaling.

Authors:  Carmen W Dessauer
Journal:  Mol Pharmacol       Date:  2009-08-14       Impact factor: 4.436

10.  The C1 and C2 domains target human type 6 adenylyl cyclase to lipid rafts and caveolae.

Authors:  Muthusamy Thangavel; Xiaoqiu Liu; Shu Qiang Sun; Joseph Kaminsky; Rennolds S Ostrom
Journal:  Cell Signal       Date:  2008-11-05       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.